Medication info

Rebavus Tablet

Prescription medicationApproval withdrawn
Ingredient · strength
Ranitidine Hydrochloride›Strength being verifiedSucralfate Hydrate›Strength being verifiedTripotassium Bismuth Dicitrate›Strength being verified
Manufacturer / importer
JW Pharmaceutical Co., Ltd.
Appearance
Green round film-coated tablet
Packaging
30 tablets/bottle, 500 tablets/bottle
Approval status
Approval withdrawn

MFDS item code 201904823 · Approved 2019.07.18

This product's status changed to Approval withdrawn on 2023.06.20. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of acid-related disorders (e.g., ulcers and gastritis) and prevention of Mendelson's syndrome
Who uses it
Adults
Adult dosage
○ Adults The usual dose is 2 tablets orally twice daily, in the morning and at bedtime, regardless of meals. 1) Gastric and duodenal ulcers Administer 2 tablets twice daily or 4 tablets once daily at bedtime. In particular, a higher healing rate may be achieved in patients with duodenal ulcers by administering 4 tablets twice daily, in the morning and at bedtime. The same dosage applies to combination therapy for ulcers caused by nonsteroidal anti-inflammatory drug administration or for prevention of gastric and duodenal ulcers during long-term administration of nonsteroidal anti-inflammatory drugs. Conditions caused by nonsteroidal anti-inflammatory drug administration generally heal within 4 weeks, and usually within 8 weeks; however, the healing period may occasionally be prolonged in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 2 tablets once daily at bedtime as maintenance therapy. 2) Reflux esophagitis Administer 2 tablets twice daily for 8 weeks or 4 tablets once daily at bedtime. However, for patients with severe reflux esophagitis, the dose may be increased to 4 tablets 4 times daily. 3) Zollinger-Ellison syndrome Begin treatment with an initial dose of 2 tablets 3 times daily and increase the dose as needed. In cases of severe disease, up to 6 g per day as ranitidine may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and administer 2 tablets twice daily. 5) Preanesthetic medication (prevention of Mendelson syndrome) Administer 2 tablets 2 hours before induction of anesthesia. In this case, it is also preferable to administer 2 tablets on the night before surgery.

Ingredients

Manufacturer
JW Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of acid-related disorders (e.g., ulcers and gastritis) and prevention of Mendelson's syndrome

  • Gastric and duodenal ulcers
  • gastritis
  • Zollinger-Ellison syndrome
  • gastroesophageal reflux disease
  • Mendelson's syndrome
  • post-surgical ulcers
View approved original text

This medication is used for digestive system-related diseases such as gastric and duodenal ulcers, gastritis, Zollinger-Ellison syndrome, and gastroesophageal reflux disease. It also helps in the prevention of ulcers following surgery and the treatment of gastric and duodenal ulcers caused by NSAIDs (non-steroidal anti-inflammatory drugs). It is also administered before anesthesia to prevent Mendelson's syndrome. It is effective in alleviating and treating symptoms of various gastrointestinal diseases.

Dosage and Administration

Adult dosage

○ Adults The usual dose is 2 tablets orally twice daily, in the morning and at bedtime, regardless of meals. 1) Gastric and duodenal ulcers Administer 2 tablets twice daily or 4 tablets once daily at bedtime. In particular, a higher healing rate may be achieved in patients with duodenal ulcers by administering 4 tablets twice daily, in the morning and at bedtime. The same dosage applies to combination therapy for ulcers caused by nonsteroidal anti-inflammatory drug administration or for prevention of gastric and duodenal ulcers during long-term administration of nonsteroidal anti-inflammatory drugs. Conditions caused by nonsteroidal anti-inflammatory drug administration generally heal within 4 weeks, and usually within 8 weeks; however, the healing period may occasionally be prolonged in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 2 tablets once daily at bedtime as maintenance therapy. 2) Reflux esophagitis Administer 2 tablets twice daily for 8 weeks or 4 tablets once daily at bedtime. However, for patients with severe reflux esophagitis, the dose may be increased to 4 tablets 4 times daily. 3) Zollinger-Ellison syndrome Begin treatment with an initial dose of 2 tablets 3 times daily and increase the dose as needed. In cases of severe disease, up to 6 g per day as ranitidine may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and administer 2 tablets twice daily. 5) Preanesthetic medication (prevention of Mendelson syndrome) Administer 2 tablets 2 hours before induction of anesthesia. In this case, it is also preferable to administer 2 tablets on the night before surgery.

Precautions

This medication should not be used in patients undergoing dialysis or with impaired kidney function. Patients who have had allergic reactions to this medication or its components should not take it. Patients with a history of acute porphyria should not be administered this medication as it may worsen symptoms. Patients who have undergone upper gastrointestinal tract surgery or women who are pregnant or may become pregnant should avoid using this medication. Premature infants, newborns, and patients who need to limit potassium intake should also be cautious. Patients with impaired liver function or a history of drug allergies, elderly individuals, and those with a history of kidney disease should exercise particular caution when using this medication. If taken in conjunction with non-steroidal anti-inflammatory drugs, regular examinations are necessary due to the increased risk of gastrointestinal bleeding. This medication may mask symptoms of gastric cancer, so it is safer for patients with gastric ulcers or middle-aged dyspeptic patients to confirm malignancy before use. Patients with gastric and duodenal ulcers who have Helicobacter pylori should also undergo eradication therapy. Patients in a critical care setting, those with hypophosphatemia, and patients with swallowing difficulties should take care when using this medication. During the use of this medication, although rare, severe allergic reactions like anaphylactic shock may occur, so symptoms should be closely monitored. If skin rash, urticaria, or bronchospasm occurs, administration should be stopped immediately. Blood tests may show leukopenia, thrombocytopenia, or liver function abnormalities, so testing is necessary if symptoms appear. Reports have indicated that cardiac rhythm abnormalities, gastrointestinal symptoms, dizziness, drowsiness, mental confusion, and other neurological symptoms may occur, necessitating caution. If muscle pain or joint pain occurs, the use of the medication should be discontinued, and a doctor should be consulted. It is advisable not to use this medication for a long time, and if there is no therapeutic effect, it should be changed to another drug. Elderly patients or those with chronic lung diseases and diabetes may be at increased risk of pneumonia, so caution is warranted. If dizziness or drowsiness is experienced during use, it is best to avoid driving or operating dangerous machinery. This medication may interact with other drugs, so it is essential to inform a doctor or pharmacist if there are other medications being taken. It is safest for pregnant or breastfeeding women not to use this medication. Safety has not been established for children, so it is advisable not to administer this medication to them. In case of overdose, emergency measures such as vomiting or gastric lavage may be required, and in certain situations, blood dialysis may be helpful. This medication reduces gastric acid secretion, which may promote bacterial growth in the stomach; therefore, long-term use may necessitate ophthalmic examinations.

Side effects

  • Anaphylactic shock
  • skin rash
  • urticaria
  • angioedema
  • fever
  • bronchospasm
  • hypotension
  • chest pain
  • granulocytopenia
  • leukopenia
Show 51 more
  • thrombocytopenia
  • elevated serum creatinine
  • elevated serum aminotransferases
  • agranulocytosis
  • pancytopenia
  • myelofibrosis
  • aplastic anemia
  • aplastic anemia
  • acquired immune hemolytic anemia
  • eosinophilia
  • general malaise
  • weakness
  • subcutaneous bleeding
  • mucosal bleeding
  • nausea
  • vomiting
  • constipation
  • diarrhea
  • abdominal bloating
  • abdominal pain
  • loss of appetite
  • dizziness
  • drowsiness
  • confusion state
  • convulsions
  • agitation
  • insomnia
  • headache
  • heaviness in the head
  • disease sensation
  • anxiety
  • mental confusion
  • depression
  • hallucination
  • blurred vision
  • involuntary movement disorder
  • consciousness disturbance
  • myoclonic spasms
  • gynecomastia
  • galactorrhea
  • erectile dysfunction
  • decreased libido
  • arthralgia
  • myalgia
  • rhabdomyolysis
  • skin rash
  • erythema multiforme
  • alopecia
  • glossitis
  • skin itching
  • acute interstitial nephritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air or moisture ingress, and it is advisable to keep it at room temperature between 1 to 30 degrees Celsius. Proper storage will help maintain the medication's efficacy for a longer period.

Appearance and packaging

Appearance

Green round film-coated tablet

Package unit

30 tablets/bottle, 500 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.